21.4 C
New York
Saturday, June 3, 2023
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Defense of the Ancients (DOTA)
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie and Music
Movie Trailers
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Truck Series (TRUCK)
Ultimate Fighting Championship (UFC)
US
USA News
Valorant
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
More
    VYNE Therapeutics Inc. (VYNE)
       6.06   -0.04(-0.6557%)
    TitleNamePayCurrency PayGenderYear BornTitle Since
    Chief Scientific Officer Dr. Iain A. Stuart Ph.D. 577426 USD 1973 N/A
    Senior Vice President of Intellectual Property Mr. David Schuz N/A USD male 1954 N/A
    Chief Financial Officer, Principal Accounting Officer & Treasurer Mr. Tyler Zeronda N/A USD male 1986 1679737032
    Consultant Dr. Darrell S. Rigel M.S., M.D., MS N/A USD 1950 N/A
    Gen. Counsel, Chief Legal Officer & Company Sec. Ms. Mutya Harsch J.D. 577910 USD female 1975 N/A
    Senior Vice President of Pharmaceutical Devel. Dr. Russell Elliott D.Phil. N/A USD 1966 N/A
    Chief Financial Officer & Treasurer Mr. Tyler Zeronda N/A USD male 1986 N/A
    Chief Executive Officer, Pres & Director Mr. David T. Domzalski 974916 USD male 1967 N/A
    SymbolDateRatingRating Score Rating Details
    VYNE 2 June, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 1 June, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 31 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 30 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 26 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 25 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 24 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 23 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 22 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 19 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 18 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 17 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 16 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 15 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 12 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 11 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 10 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 9 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 8 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 5 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 4 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 3 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 2 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 1 May, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 28 April, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 27 April, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 26 April, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 25 April, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 24 April, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 21 April, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 20 April, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 19 April, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 18 April, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 17 April, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 14 April, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 13 April, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 12 April, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 10 April, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 31 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 30 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 29 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 28 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 27 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 24 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 23 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 21 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 20 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 17 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 15 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 14 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 13 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 10 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 9 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 8 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 7 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 6 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 3 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 2 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 1 March, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 28 February, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 27 February, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 24 February, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 23 February, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 22 February, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 21 February, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 17 February, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 16 February, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 13 February, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 10 February, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 9 February, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 8 February, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 6 February, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 3 February, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 2 February, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 1 February, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 31 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 30 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 27 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 26 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 25 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 24 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 23 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 20 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 18 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 17 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 13 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 12 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 11 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 10 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 9 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 6 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 5 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 4 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 3 January, 2023 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 30 December, 2022 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 29 December, 2022 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 28 December, 2022 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 27 December, 2022 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 23 December, 2022 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    VYNE 22 December, 2022 B 3 Rating DCF: (Strong Buy)
    Rating ROE: (Sell)
    Rating DCF: (Sell)
    Rating DE: (Neutral)
    Rating PE: (Neutral)
    Rating PB: (Neutral)
    HolderSharesDate ReportedChange
    STALEY CAPITAL ADVISERS INC 3473 31 December, 2022 0
    RUSSELL INVESTMENTS GROUP, LTD. 188 31 December, 2022 3375
    CSS LLC/IL 1341 31 December, 2022 0
    TWO SIGMA SECURITIES, LLC 1051 31 December, 2022 1051
    SUSQUEHANNA INTERNATIONAL GROUP, LLP 916 31 December, 2022 -469
    CITADEL ADVISORS LLC 2998 31 December, 2022 -1814
    NORTHERN TRUST CORP 4971 31 December, 2022 4
    BANK OF NEW YORK MELLON CORP 1480 31 December, 2022 58
    MARINER, LLC 695 31 December, 2022 -81
    BEACON POINTE ADVISORS, LLC 4112 31 December, 2022 -55
    MACKENZIE FINANCIAL CORP 7496 31 December, 2022 0
    DSC ADVISORS, L.P. 87223 31 December, 2022 -61111
    MORGAN STANLEY 1298 31 December, 2022 -16
    MILLENNIUM MANAGEMENT LLC 27112 31 December, 2022 16072
    TOBIAS FINANCIAL ADVISORS, INC. 612 31 December, 2022 612
    FIRST MANHATTAN CO 143 31 December, 2022 143
    STATE STREET CORP 11670 31 December, 2022 0
    FEDERATED HERMES, INC. 128 31 December, 2022 0
    TOWER RESEARCH CAPITAL LLC (TRC) 1434 31 December, 2022 -1471
    TEKLA CAPITAL MANAGEMENT LLC 7522 31 December, 2022 0
    BLACKROCK INC. 49213 31 December, 2022 -14
    LPL FINANCIAL LLC 940 31 December, 2022 -400
    UBS GROUP AG 3038 31 December, 2022 44217
    GEODE CAPITAL MANAGEMENT, LLC 24950 31 December, 2022 -62
    DELTEC ASSET MANAGEMENT LLC 1667 31 December, 2022 0
    RENAISSANCE TECHNOLOGIES LLC 48158 31 December, 2022 -3454
    VANGUARD GROUP INC 91701 31 December, 2022 1118
    THRIVENT FINANCIAL FOR LUTHERANS 3060 31 December, 2022 0
    BANK OF AMERICA CORP /DE/ 4934 31 December, 2022 130
    INVESTORS RESEARCH CORP 9 31 December, 2022 150
    FRANKLIN RESOURCES INC 5341 31 December, 2022 0
    NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 49 31 December, 2022 49
    CETERA ADVISOR NETWORKS LLC 6389 31 December, 2022 0
    JANE STREET GROUP, LLC 1027 31 December, 2022 -1786
    WELLS FARGO & COMPANY/MN 87 31 December, 2022 87
    STEWARD PARTNERS INVESTMENT ADVISORY, LLC 36 31 December, 2022 36
    TEKLA CAPITAL MANAGEMENT LLC 7522 30 September, 2022 0
    CSS LLC/IL 1341 30 September, 2022 -63
    VIRTU FINANCIAL LLC 3415 30 September, 2022 -188
    SymbolTransaction DateReporting CikSecurities Owned Company CikReporting NameAcquistion Or DispositionForm Type Securities TransactedSecurity NameLink
    VYNE 31 May, 2023 0001727809 25907 0001566044 Harsch Mutya A 4 3664 Common Stock View
    VYNE 31 May, 2023 0001727794 53414 0001566044 Domzalski David A 4 2766 Common Stock View
    VYNE 31 March, 2023 0001867033 8108 0001566044 Zeronda Tyler D 4 384 Common Stock View
    VYNE 31 March, 2023 0001727756 10390 0001566044 Stuart Iain D 4 480 Common Stock View
    VYNE 31 March, 2023 0001727809 22243 0001566044 Harsch Mutya D 4 478 Common Stock View
    VYNE 31 March, 2023 0001727794 50648 0001566044 Domzalski David D 4 2734 Common Stock View
    VYNE 31 December, 2022 0001727809 229144 0001566044 Harsch Mutya D 4 1813 Common Stock View
    VYNE 31 December, 2022 0001727756 220252 0001566044 Stuart Iain D 4 1720 Common Stock View
    VYNE 31 December, 2022 0001867033 173005 0001566044 Zeronda Tyler D 4 354 Common Stock View
    VYNE 31 December, 2022 0001727794 1064290 0001566044 Domzalski David D 4 10685 Common Stock View
    VYNE 30 November, 2022 0001727794 1074975 0001566044 Domzalski David A 4 34705 Common Stock View
    VYNE 30 September, 2022 0001867033 173359 0001566044 Zeronda Tyler D 4 353 Common Stock View
    VYNE 30 September, 2022 0001727756 221972 0001566044 Stuart Iain D 4 1719 Common Stock View
    VYNE 30 September, 2022 0001727809 230957 0001566044 Harsch Mutya D 4 1813 Common Stock View
    VYNE 30 September, 2022 0001727794 1040270 0001566044 Domzalski David D 4 10683 Common Stock View
    VYNE 10 August, 2022 0001632295 20500 0001566044 Sandoval Elisabeth A 4 20500 Stock Options View
    VYNE 10 August, 2022 0001055404 20500 0001566044 LEPORE PATRICK G A 4 20500 Stock Options View
    VYNE 10 August, 2022 0001374180 20500 0001566044 Bruno Anthony D A 4 20500 Stock Options View
    VYNE 10 August, 2022 0001417397 20500 0001566044 Basta Steven L A 4 20500 Stock Options View
    VYNE 10 August, 2022 0001240499 20500 0001566044 BARBARI SHARON A 4 20500 Stock Options View
    VYNE 30 June, 2022 0001867033 173712 0001566044 Zeronda Tyler D 4 354 Common Stock View
    VYNE 30 June, 2022 0001727756 223691 0001566044 Stuart Iain D 4 1719 Common Stock View
    VYNE 30 June, 2022 0001727809 232770 0001566044 Harsch Mutya D 4 1813 Common Stock View
    VYNE 30 June, 2022 0001727794 1050953 0001566044 Domzalski David D 4 10683 Common Stock View
    VYNE 31 May, 2022 0001867033 174066 0001566044 Zeronda Tyler A 4 12510 Common Stock View
    VYNE 31 May, 2022 0001727794 1061636 0001566044 Domzalski David A 4 11887 Common Stock View
    VYNE 31 March, 2022 0001867033 161556 0001566044 Zeronda Tyler D 4 773 Common Stock View
    VYNE 31 March, 2022 0001727756 225410 0001566044 Stuart Iain D 4 3469 Common Stock View
    VYNE 31 March, 2022 0001727809 234583 0001566044 Harsch Mutya D 4 3630 Common Stock View
    VYNE 31 March, 2022 0001727794 1049749 0001566044 Domzalski David D 4 23186 Common Stock View
    VYNE 17 March, 2022 0001867033 75000 0001566044 Zeronda Tyler A 4 75000 Stock Options View
    VYNE 17 March, 2022 0001727756 75000 0001566044 Stuart Iain A 4 75000 Stock Options View
    VYNE 17 March, 2022 0001727809 75000 0001566044 Harsch Mutya A 4 75000 Stock Options View
    VYNE 17 March, 2022 0001727794 1072935 0001566044 Domzalski David A 4 312302 Common Stock View
    VYNE 31 December, 2021 0001867033 87329 0001566044 Zeronda Tyler D 4 206 Common Stock View
    VYNE 31 December, 2021 0001727756 153879 0001566044 Stuart Iain D 4 1250 Common Stock View
    VYNE 31 December, 2021 0001727809 163213 0001566044 Harsch Mutya D 4 1484 Common Stock View
    VYNE 31 December, 2021 0001727794 760633 0001566044 Domzalski David D 4 6887 Common Stock View
    VYNE 30 November, 2021 0001867033 87535 0001566044 Zeronda Tyler A 4 4187 Common Stock View
    VYNE 30 November, 2021 0001055404 62500 0001566044 LEPORE PATRICK G A 4 12500 Common Stock View
    VYNE 30 November, 2021 0001727794 767520 0001566044 Domzalski David A 4 4705 Common Stock View
    VYNE 30 September, 2021 0001867033 83348 0001566044 Zeronda Tyler D 4 206 Common Stock View
    VYNE 30 September, 2021 0001727756 155129 0001566044 Stuart Iain D 4 1480 Common Stock View
    VYNE 30 September, 2021 0001727809 164697 0001566044 Harsch Mutya D 4 1484 Common Stock View
    VYNE 30 September, 2021 0001727794 762815 0001566044 Domzalski David D 4 13096 Common Stock View
    VYNE 2 September, 2021 0001867033 83554 0001566044 Zeronda Tyler A 4 60859 Common Stock View
    VYNE 2 September, 2021 0001867033 60860 0001566044 Zeronda Tyler A 4 60860 Stock Options View
    VYNE 2 September, 2021 0001727756 156609 0001566044 Stuart Iain A 4 60859 Common Stock View
    VYNE 2 September, 2021 0001727756 60860 0001566044 Stuart Iain A 4 60860 Stock Options View
    VYNE 2 September, 2021 0001727809 166181 0001566044 Harsch Mutya A 4 60859 Common Stock View
    VYNE 2 September, 2021 0001727809 60860 0001566044 Harsch Mutya A 4 60860 Stock Options View
    VYNE 2 September, 2021 0001727794 775911 0001566044 Domzalski David A 4 320312 Common Stock View
    VYNE 2 September, 2021 0001727794 320313 0001566044 Domzalski David A 4 320313 Stock Options View
    VYNE 25 August, 2021 0001055404 50000 0001566044 LEPORE PATRICK G A 4 12500 Common Stock View
    VYNE 16 August, 2021 0001224962 4935057 0001566044 PERCEPTIVE ADVISORS LLC D 4 250000 Common Stock View
    VYNE 13 August, 2021 0001224962 5185057 0001566044 PERCEPTIVE ADVISORS LLC D 4 250000 Common Stock View
    VYNE 12 August, 2021 0001224962 5435057 0001566044 PERCEPTIVE ADVISORS LLC D 4 338897 Common Stock View
    VYNE 19 July, 2021 0001632295 20500 0001566044 Sandoval Elisabeth A 4 20500 Stock Options View
    VYNE 19 July, 2021 0001055404 20500 0001566044 LEPORE PATRICK G A 4 20500 Stock Options View
    VYNE 19 July, 2021 0001374180 20500 0001566044 Bruno Anthony D A 4 20500 Stock Options View
    VYNE 19 July, 2021 0001327501 20500 0001566044 Bright Rex A 4 20500 Stock Options View
    VYNE 19 July, 2021 0001417397 20500 0001566044 Basta Steven L A 4 20500 Stock Options View
    VYNE 19 July, 2021 0001240499 20500 0001566044 BARBARI SHARON A 4 20500 Stock Options View
    VYNE 30 June, 2021 0001867033 22695 0001566044 Zeronda Tyler D 4 700 Common Stock View
    VYNE 30 June, 2021 0001759703 109246 0001566044 Wiley Matthew T. D 4 5151 Common Stock View
    VYNE 30 June, 2021 0001727756 95750 0001566044 Stuart Iain D 4 3083 Common Stock View
    VYNE 30 June, 2021 0001727809 105322 0001566044 Harsch Mutya D 4 3551 Common Stock View
    VYNE 30 June, 2021 0001727794 455599 0001566044 Domzalski David D 4 18859 Common Stock View
    VYNE 18 June, 2021 0001867033 23395 0001566044 Zeronda Tyler D 3 0 Common Stock View
    VYNE 18 June, 2021 0001867033 0 0001566044 Zeronda Tyler D 3 13504 Stock Option View
    VYNE 18 June, 2021 0001867033 0 0001566044 Zeronda Tyler D 3 4375 Stock Option View
    VYNE 18 June, 2021 0001867033 0 0001566044 Zeronda Tyler D 3 9375 Stock Option View
    VYNE 18 June, 2021 0001867033 0 0001566044 Zeronda Tyler D 3 18834 Stock Option View
    VYNE 28 May, 2021 0001616284 116468 0001566044 Saik Andrew A 4 3017 Common Stock View
    VYNE 28 May, 2021 0001727794 474458 0001566044 Domzalski David A 4 941 Common Stock View
    VYNE 26 May, 2021 0001055404 37500 0001566044 LEPORE PATRICK G A 4 12500 Common Stock View
    VYNE 6 May, 2021 0001224962 5773954 0001566044 PERCEPTIVE ADVISORS LLC D 4 1000000 Common Stock View
    VYNE 31 March, 2021 0001759703 114397 0001566044 Wiley Matthew T. D 4 2573 Common Stock View
    VYNE 31 March, 2021 0001727756 98833 0001566044 Stuart Iain D 4 1945 Common Stock View
    VYNE 31 March, 2021 0001616284 113451 0001566044 Saik Andrew D 4 762 Common Stock View
    VYNE 31 March, 2021 0001727809 108873 0001566044 Harsch Mutya D 4 1765 Common Stock View
    VYNE 31 March, 2021 0001727794 473517 0001566044 Domzalski David D 4 6316 Common Stock View
    VYNE 15 March, 2021 0001055404 25000 0001566044 LEPORE PATRICK G A 4 12500 Common Stock View
    VYNE 22 February, 2021 0001759703 116970 0001566044 Wiley Matthew T. A 4 27675 Common Stock View
    VYNE 22 February, 2021 0001759703 64575 0001566044 Wiley Matthew T. A 4 64575 Stock Options View
    VYNE 22 February, 2021 0001727756 100778 0001566044 Stuart Iain A 4 29213 Common Stock View
    VYNE 22 February, 2021 0001727756 68162 0001566044 Stuart Iain A 4 68162 Stock Options View
    VYNE 22 February, 2021 0001616284 114213 0001566044 Saik Andrew A 4 29213 Common Stock View
    VYNE 22 February, 2021 0001616284 68162 0001566044 Saik Andrew A 4 68162 Stock Options View
    VYNE 22 February, 2021 0001727809 110638 0001566044 Harsch Mutya A 4 29213 Common Stock View
    VYNE 22 February, 2021 0001727809 68162 0001566044 Harsch Mutya A 4 68162 Stock Options View
    VYNE 22 February, 2021 0001727794 479833 0001566044 Domzalski David A 4 153750 Common Stock View
    VYNE 22 February, 2021 0001727794 358750 0001566044 Domzalski David A 4 358750 Stock Options View
    VYNE 28 January, 2021 0001224962 27095819 0001566044 PERCEPTIVE ADVISORS LLC A 4 4219409 Common Stock View
    VYNE 31 December, 2020 0001759703 357181 0001566044 Wiley Matthew T. D 4 1541 Common Stock View
    VYNE 31 December, 2020 0001727756 286262 0001566044 Stuart Iain D 4 2378 Common Stock View
    VYNE 31 December, 2020 0001727809 325703 0001566044 Harsch Mutya D 4 1822 Common Stock View
    VYNE 31 December, 2020 0001727794 1304334 0001566044 Domzalski David D 4 9656 Common Stock View
    VYNE 3 December, 2020 0001055404 50000 0001566044 LEPORE PATRICK G A 4 50000 Common Stock View
    VYNE 30 November, 2020 0001759703 358722 0001566044 Wiley Matthew T. A 4 7838 Common Stock View
    SymbolDatePeriodDownload XLSX File
    VYNE 2022 FY Download XLSX File
    VYNE 2021 FY Download XLSX File
    VYNE 2020 FY Download XLSX File
    VYNE 2019 FY Download XLSX File
    VYNE 2018 FY Download XLSX File
    VYNE 2017 FY Download XLSX File
    VYNE 2022 Q1 Download XLSX File
    VYNE 2022 Q3 Download XLSX File
    VYNE 2022 Q4 Download XLSX File
    VYNE 2022 Q2 Download XLSX File
    VYNE 2021 Q3 Download XLSX File
    VYNE 2021 Q1 Download XLSX File
    VYNE 2021 Q2 Download XLSX File
    VYNE 2021 Q4 Download XLSX File
    VYNE 2020 Q3 Download XLSX File
    VYNE 2020 Q4 Download XLSX File
    VYNE 2020 Q1 Download XLSX File
    VYNE 2020 Q2 Download XLSX File
    VYNE 2019 Q3 Download XLSX File
    VYNE 2019 Q4 Download XLSX File
    VYNE 2019 Q1 Download XLSX File
    VYNE 2019 Q2 Download XLSX File
    VYNE 2018 Q2 Download XLSX File
    VYNE 2018 Q4 Download XLSX File
    VYNE 2018 Q3 Download XLSX File
    VYNE 2018 Q1 Download XLSX File
    VYNE 2017 Q4 Download XLSX File

    Chart

    Company NameVYNE Therapeutics Inc.
    SymbolVYNE
    CurrencyUSD
    Price6.06
    Exchange NameNASDAQ Global Select (NASDAQ)
    IndustryBiotechnology
    Websitehttps://www.vynetherapeutics.com
    CEOMr. David T. Domzalski
    SectorHealthcare
    CountryUS
    Full Time Employees12
    Phone800 775 7936
    Address520 U.S. Highway 22
    CityBridgewater
    StateNJ
    Zip08807

    Financials Yearly

    Financials Quarterly

    Upgrades & Downgrades

    Company Historical Earnings

    DateSymbolEPSEPS EstimatedTimeRevenueRevenue Estimated
    9 May, 2024 VYNE bmo
    7 March, 2024 VYNE bmo
    8 November, 2023 VYNE bmo
    10 August, 2023 VYNE bmo 100000
    11 May, 2023 VYNE -1.74 -1.74 bmo 99000
    9 March, 2023 VYNE -3.33 -3.33 bmo 60000
    10 November, 2022 VYNE -2.88 -2.88 bmo 167000
    12 August, 2022 VYNE -2.34 -2.34 bmo 126000
    12 May, 2022 VYNE -2.52 -2.52 bmo 178000
    17 March, 2022 VYNE -3.6 -3.6 bmo 2292000 4120000
    10 November, 2021 VYNE -6.48 -6.48 bmo 4086000 3095454
    12 August, 2021 VYNE -6.3 -6.3 bmo 4258000 7530000
    6 May, 2021 VYNE -6.66 -6.66 bmo 4119000 4520853
    4 March, 2021 VYNE -9.9 -9.9 bmo 4286000
    5 November, 2020 VYNE -10.8 -10.8 bmo 3269000 14049933.333333
    6 August, 2020 VYNE -14.4 -14.4 bmo 11688000 22137500
    11 May, 2020 VYNE -68.4 -68.4 bmo 1750000 1564059.375
    3 March, 2020 VYNE -64.08 -64.08 bmo 11561247.191011
    31 October, 2019 VYNE -50.4 -50.4 bmo 13636700
    1 August, 2019 VYNE -49.68 -49.68 bmo 15092000
    2 May, 2019 VYNE -58.32 -58.32 bmo 12397000
    27 February, 2019 VYNE -54.72 -54.72 bmo 13212592.105263
    7 November, 2018 VYNE -40.32 -40.32 bmo 19702375
    1 August, 2018 VYNE -25.92 -25.92 bmo 10143000 27204527.777778
    9 May, 2018 VYNE -51.84 -51.84 bmo 497000 11363916.666667
    28 March, 2018 VYNE -129.6 -129.6 bmo 2775000 4752183.3333333
    30 September, 2017 VYNE -50.98991 -50.98991 bmo 909000
    30 June, 2017 VYNE -38.39218 -38.39218 bmo 449000
    31 March, 2017 VYNE -34.1555 -34.1555 bmo 449000
    31 December, 2016 VYNE -30.18089 -30.18089 bmo 450000

    Company Profile

    CEO Mr. David T. Domzalski
    Sector Healthcare
    Industry Biotechnology
    Website https://www.vynetherapeutics.com
    Exchange NASDAQ Global Select
    Description VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in Phase IIa preclinical trial for the treatment of mild-to-moderate atopic dermatitis. It is also developing VYN201, a bromodomain and extra-terminal (BET) inhibitor for various immuno-inflammatory diseases, including skin diseases; and VYN202, BET inhibitor compounds that are selective for bromodomain 2. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.

    FREE

    Get the most important news and analyses for Free.

    Thank you for subscribing.

    Something went wrong.